-
1
-
-
84894552888
-
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions
-
Goede V, Fischer K, Busch R, et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014;370(12):1101-1110.
-
(2014)
N Engl J Med
, vol.370
, Issue.12
, pp. 1101-1110
-
-
Goede, V.1
Fischer, K.2
Busch, R.3
-
2
-
-
84896692766
-
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
-
Furman RR, Sharman JP, Coutre SE, et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med. 2014;370(11):997-1007.
-
(2014)
N Engl J Med
, vol.370
, Issue.11
, pp. 997-1007
-
-
Furman, R.R.1
Sharman, J.P.2
Coutre, S.E.3
-
3
-
-
84879748062
-
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
-
Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369(1):32-42.
-
(2013)
N Engl J Med
, vol.369
, Issue.1
, pp. 32-42
-
-
Byrd, J.C.1
Furman, R.R.2
Coutre, S.E.3
-
4
-
-
84925484937
-
Determination of recommended phase 2 dose of ABT-199 (GDC-0199) combined with rituximab (R) in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)
-
abstract
-
Roberts AW, Ma S, Brander DM, et al. Determination of recommended phase 2 dose of ABT-199 (GDC-0199) combined with rituximab (R) in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) [abstract]. Blood. 2014;124(21). Abstract 325.
-
(2014)
Blood
, vol.124
, Issue.21
-
-
Roberts, A.W.1
Ma, S.2
Brander, D.M.3
-
5
-
-
84904411900
-
Evolving understanding of the CLL genome
-
Gruber M, Wu CJ. Evolving understanding of the CLL genome. Semin Hematol. 2014;51(3):177-187.
-
(2014)
Semin Hematol
, vol.51
, Issue.3
, pp. 177-187
-
-
Gruber, M.1
Wu, C.J.2
-
6
-
-
84855370035
-
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia
-
Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365(26):2497-2506.
-
(2011)
N Engl J Med
, vol.365
, Issue.26
, pp. 2497-2506
-
-
Wang, L.1
Lawrence, M.S.2
Wan, Y.3
-
7
-
-
79960353160
-
Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation
-
Fabbri G, Rasi S, Rossi D, et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med. 2011;208(7):1389-1401.
-
(2011)
J Exp Med
, vol.208
, Issue.7
, pp. 1389-1401
-
-
Fabbri, G.1
Rasi, S.2
Rossi, D.3
-
8
-
-
79960036578
-
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
-
Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011;475(7354):101-105.
-
(2011)
Nature
, vol.475
, Issue.7354
, pp. 101-105
-
-
Puente, X.S.1
Pinyol, M.2
Quesada, V.3
-
9
-
-
84555171449
-
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
-
Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet. 2011;44(1):47-52.
-
(2011)
Nat Genet
, vol.44
, Issue.1
, pp. 47-52
-
-
Quesada, V.1
Conde, L.2
Villamor, N.3
-
10
-
-
84878551940
-
POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia
-
Ramsay AJ, Quesada V, Foronda M, et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet. 2013;45(5):526-530.
-
(2013)
Nat Genet
, vol.45
, Issue.5
, pp. 526-530
-
-
Ramsay, A.J.1
Quesada, V.2
Foronda, M.3
-
11
-
-
84886851785
-
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
-
Fabbri G, Khiabanian H, Holmes AB, et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med. 2013;210(11):2273-2288.
-
(2013)
J Exp Med
, vol.210
, Issue.11
, pp. 2273-2288
-
-
Fabbri, G.1
Khiabanian, H.2
Holmes, A.B.3
-
12
-
-
84874102335
-
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
-
Landau DA, Carter SL, Stojanov P, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013;152(4):714-726.
-
(2013)
Cell
, vol.152
, Issue.4
, pp. 714-726
-
-
Landau, D.A.1
Carter, S.L.2
Stojanov, P.3
-
13
-
-
75649133610
-
Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia
-
Kanduri M, Cahill N, Göransson H, et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood. 2010;115(2):296-305.
-
(2010)
Blood
, vol.115
, Issue.2
, pp. 296-305
-
-
Kanduri, M.1
Cahill, N.2
Göransson, H.3
-
14
-
-
84861922114
-
Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia
-
Pei L, Choi J-H, Liu J, et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics. 2012;7(6):567-578.
-
(2012)
Epigenetics
, vol.7
, Issue.6
, pp. 567-578
-
-
Pei, L.1
Choi, J.-H.2
Liu, J.3
-
15
-
-
84868198427
-
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
-
Kulis M, Heath S, Bibikova M, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet. 2012;44(11):1236-1242.
-
(2012)
Nat Genet
, vol.44
, Issue.11
, pp. 1236-1242
-
-
Kulis, M.1
Heath, S.2
Bibikova, M.3
-
16
-
-
84873570131
-
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
-
Cahill N, Bergh A-C, Kanduri M, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia. 2013;27(1):150-158.
-
(2013)
Leukemia
, vol.27
, Issue.1
, pp. 150-158
-
-
Cahill, N.1
Bergh, A.-C.2
Kanduri, M.3
-
17
-
-
84895783051
-
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia
-
Oakes CC, Claus R, Gu L, et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discov. 2014;4(3):348-361.
-
(2014)
Cancer Discov
, vol.4
, Issue.3
, pp. 348-361
-
-
Oakes, C.C.1
Claus, R.2
Gu, L.3
-
18
-
-
84919469035
-
Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia
-
Landau DA, Clement K, Ziller MJ, et al. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell. 2014;26(6):813-825.
-
(2014)
Cancer Cell
, vol.26
, Issue.6
, pp. 813-825
-
-
Landau, D.A.1
Clement, K.2
Ziller, M.J.3
-
19
-
-
72949093335
-
From pathogenesis to treatment of chronic lymphocytic leukaemia
-
Zenz T, Mertens D, Küppers R, Döhner H, Stilgenbauer S. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer. 2010;10(1):37-50.
-
(2010)
Nat Rev Cancer
, vol.10
, Issue.1
, pp. 37-50
-
-
Zenz, T.1
Mertens, D.2
Küppers, R.3
Döhner, H.4
Stilgenbauer, S.5
-
20
-
-
84879419178
-
The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia
-
Malek SN. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia. Oncogene. 2013;32(23):2805-2817.
-
(2013)
Oncogene
, vol.32
, Issue.23
, pp. 2805-2817
-
-
Malek, S.N.1
-
21
-
-
0034727833
-
Genomic aberrations and survival in chronic lymphocytic leukemia
-
Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910-1916.
-
(2000)
N Engl J Med
, vol.343
, Issue.26
, pp. 1910-1916
-
-
Döhner, H.1
Stilgenbauer, S.2
Benner, A.3
-
22
-
-
84863957729
-
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia
-
Brown JR, Hanna M, Tesar B, et al. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res. 2012;18(14):3791-3802.
-
(2012)
Clin Cancer Res
, vol.18
, Issue.14
, pp. 3791-3802
-
-
Brown, J.R.1
Hanna, M.2
Tesar, B.3
-
23
-
-
18744396337
-
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
-
Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002;99(24):15524-15529.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, Issue.24
, pp. 15524-15529
-
-
Calin, G.A.1
Dumitru, C.D.2
Shimizu, M.3
-
24
-
-
84892833777
-
Discovery and saturation analysis of cancer genes across 21 tumour types
-
Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505(7484):495-501.
-
(2014)
Nature
, vol.505
, Issue.7484
, pp. 495-501
-
-
Lawrence, M.S.1
Stojanov, P.2
Mermel, C.H.3
-
25
-
-
84878396846
-
SF3B1 mutations in chronic lymphocytic leukemia
-
Wan Y, Wu CJ. SF3B1 mutations in chronic lymphocytic leukemia. Blood. 2013;121(23):4627-4634.
-
(2013)
Blood
, vol.121
, Issue.23
, pp. 4627-4634
-
-
Wan, Y.1
Wu, C.J.2
-
26
-
-
84979023963
-
Novel putative driver gene mutations in chronic lymphocytic leukemia (CLL): Results from a combined analysis of whole-exome sequencing of 262 primary CLL samples
-
abstract
-
Landau DA, Stewart C, Reiter JG, et al. Novel putative driver gene mutations in chronic lymphocytic leukemia (CLL): results from a combined analysis of whole-exome sequencing of 262 primary CLL samples [abstract]. Blood. 2014;124(21). Abstract 1952.
-
(2014)
Blood
, vol.124
, Issue.21
-
-
Landau, D.A.1
Stewart, C.2
Reiter, J.G.3
-
27
-
-
84874428346
-
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
-
Rossi D, Rasi S, Spina V, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood. 2013;121(8):1403-1412.
-
(2013)
Blood
, vol.121
, Issue.8
, pp. 1403-1412
-
-
Rossi, D.1
Rasi, S.2
Spina, V.3
-
29
-
-
84891866590
-
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients
-
Jeromin S, Weissmann S, Haferlach C, et al. SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. Leukemia. 2014;28(1):108-117.
-
(2014)
Leukemia
, vol.28
, Issue.1
, pp. 108-117
-
-
Jeromin, S.1
Weissmann, S.2
Haferlach, C.3
-
30
-
-
84895798179
-
On the way towards a 'CLL prognostic index': Focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort
-
Cortese D, Sutton L-A, Cahill N, et al. On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort. Leukemia. 2014;28(3):710-713.
-
(2014)
Leukemia
, vol.28
, Issue.3
, pp. 710-713
-
-
Cortese, D.1
Sutton, L.-A.2
Cahill, N.3
-
31
-
-
84871798242
-
Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial
-
Skowronska A, Parker A, Ahmed G, et al. Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial. J Clin Oncol. 2012;30(36):4524-4532.
-
(2012)
J Clin Oncol
, vol.30
, Issue.36
, pp. 4524-4532
-
-
Skowronska, A.1
Parker, A.2
Ahmed, G.3
-
32
-
-
84872469222
-
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
-
Oscier DG, Rose-Zerilli MJJ, Winkelmann N, et al. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood. 2013;121(3):468-475.
-
(2013)
Blood
, vol.121
, Issue.3
, pp. 468-475
-
-
Oscier, D.G.1
Rose-Zerilli, M.J.J.2
Winkelmann, N.3
-
33
-
-
84901408966
-
Gene mutations and treatment outcome in chronic lymphocytic leukemia: Results from the CLL8 trial
-
Stilgenbauer S, Schnaiter A, Paschka P, et al. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood. 2014;123(21):3247-3254.
-
(2014)
Blood
, vol.123
, Issue.21
, pp. 3247-3254
-
-
Stilgenbauer, S.1
Schnaiter, A.2
Paschka, P.3
-
34
-
-
84887204270
-
NOTCH1, SF3B1, and TP53 mutations in fludarabinerefractory CLL patients treated with alemtuzumab: Results from the CLL2H trial of the GCLLSG
-
Schnaiter A, Paschka P, Rossi M, et al. NOTCH1, SF3B1, and TP53 mutations in fludarabinerefractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG. Blood. 2013;122(7):1266-1270.
-
(2013)
Blood
, vol.122
, Issue.7
, pp. 1266-1270
-
-
Schnaiter, A.1
Paschka, P.2
Rossi, M.3
-
35
-
-
84879173666
-
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: Six-year follow-up of the GCLLSG CLL3X trial
-
Dreger P, Schnaiter A, Zenz T, et al. TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial. Blood. 2013;121(16):3284-3288.
-
(2013)
Blood
, vol.121
, Issue.16
, pp. 3284-3288
-
-
Dreger, P.1
Schnaiter, A.2
Zenz, T.3
-
36
-
-
84937899116
-
Mutational landscape of 118 relapsed chronic lymphocytic leukemia clinical trial samples; evidence for a multiple-hit profile using targeted next generation sequencing
-
abstract
-
Robbe P, Guièze R, Clifford RM, et al. Mutational landscape of 118 relapsed chronic lymphocytic leukemia clinical trial samples; evidence for a multiple-hit profile using targeted next generation sequencing [abstract]. Blood. 2014;124(21). Abstract 1974.
-
(2014)
Blood
, vol.124
, Issue.21
-
-
Robbe, P.1
Guièze, R.2
Clifford, R.M.3
-
37
-
-
84906908742
-
Acquired initiating mutations in early hematopoietic cells of CLL patients
-
Damm F, Mylonas E, Cosson A, et al. Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov. 2014;4(9):1088-1101.
-
(2014)
Cancer Discov
, vol.4
, Issue.9
, pp. 1088-1101
-
-
Damm, F.1
Mylonas, E.2
Cosson, A.3
-
38
-
-
84905990862
-
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL
-
Wang L, Shalek AK, Lawrence M, et al. Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL. Blood. 2014;124(7):1089-1098.
-
(2014)
Blood
, vol.124
, Issue.7
, pp. 1089-1098
-
-
Wang, L.1
Shalek, A.K.2
Lawrence, M.3
-
39
-
-
84893699492
-
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
-
Ferreira PG, Jares P, Rico D, et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 2014;24(2):212-226.
-
(2014)
Genome Res
, vol.24
, Issue.2
, pp. 212-226
-
-
Ferreira, P.G.1
Jares, P.2
Rico, D.3
-
40
-
-
84929291816
-
The impact of SF3B1 mutations in CLL on the DNA-damage response
-
Te Raa GD, Derks IA, Navrkalova V, et al. The impact of SF3B1 mutations in CLL on the DNA-damage response. Leukemia. 2015;29(5):1133-1142.
-
(2015)
Leukemia
, vol.29
, Issue.5
, pp. 1133-1142
-
-
Te Raa, G.D.1
Derks, I.A.2
Navrkalova, V.3
-
41
-
-
84897585594
-
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage
-
Clifford R, Louis T, Robbe P, et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood. 2014;123(7):1021-1031.
-
(2014)
Blood
, vol.123
, Issue.7
, pp. 1021-1031
-
-
Clifford, R.1
Louis, T.2
Robbe, P.3
-
42
-
-
84859398461
-
Nurture versus nature: The microenvironment in chronic lymphocytic leukemia
-
Burger JA. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2011;2011:96-103.
-
(2011)
Hematology Am Soc Hematol Educ Program
, vol.2011
, pp. 96-103
-
-
Burger, J.A.1
-
43
-
-
84902183019
-
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib
-
Woyach JA, Furman RR, Liu TM, et al. Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib. N Engl J Med. 2014;370(24):2286-2294.
-
(2014)
N Engl J Med
, vol.370
, Issue.24
, pp. 2286-2294
-
-
Woyach, J.A.1
Furman, R.R.2
Liu, T.M.3
-
44
-
-
84899084563
-
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness
-
Messina M, Del Giudice I, Khiabanian H, et al. Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. Blood. 2014;123(15):2378-2388.
-
(2014)
Blood
, vol.123
, Issue.15
, pp. 2378-2388
-
-
Messina, M.1
Del Giudice, I.2
Khiabanian, H.3
-
45
-
-
0017167185
-
The clonal evolution of tumor cell populations
-
Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194(4260):23-28.
-
(1976)
Science
, vol.194
, Issue.4260
, pp. 23-28
-
-
Nowell, P.C.1
-
46
-
-
84856013431
-
Clonal evolution in cancer
-
Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481(7381):306-313.
-
(2012)
Nature
, vol.481
, Issue.7381
, pp. 306-313
-
-
Greaves, M.1
Maley, C.C.2
-
47
-
-
57149118627
-
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia
-
Mullighan CG, Phillips LA, Su X, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008;322(5906):1377-1380.
-
(2008)
Science
, vol.322
, Issue.5906
, pp. 1377-1380
-
-
Mullighan, C.G.1
Phillips, L.A.2
Su, X.3
-
48
-
-
84878411259
-
Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia
-
Ouillette P, Saiya-Cork K, Seymour E, Li C, Shedden K, Malek SN. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia. Clin Cancer Res. 2013;19(11):2893-2904.
-
(2013)
Clin Cancer Res
, vol.19
, Issue.11
, pp. 2893-2904
-
-
Ouillette, P.1
Saiya-Cork, K.2
Seymour, E.3
Li, C.4
Shedden, K.5
Malek, S.N.6
-
49
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883-892.
-
(2012)
N Engl J Med
, vol.366
, Issue.10
, pp. 883-892
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
-
50
-
-
84862526929
-
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
-
Shah SP, Roth A, Goya R, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395-399.
-
(2012)
Nature
, vol.486
, Issue.7403
, pp. 395-399
-
-
Shah, S.P.1
Roth, A.2
Goya, R.3
-
51
-
-
84862776906
-
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
-
Ding L, Ley TJ, Larson DE, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481(7382):506-510.
-
(2012)
Nature
, vol.481
, Issue.7382
, pp. 506-510
-
-
Ding, L.1
Ley, T.J.2
Larson, D.E.3
-
52
-
-
84991237207
-
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia
-
Wang J, Khiabanian H, Rossi D, et al. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia. ELife. 2014;3.
-
(2014)
ELife
, pp. 3
-
-
Wang, J.1
Khiabanian, H.2
Rossi, D.3
-
53
-
-
73649116987
-
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia
-
Klein U, Lia M, Crespo M, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell. 2010;17(1):28-40.
-
(2010)
Cancer Cell
, vol.17
, Issue.1
, pp. 28-40
-
-
Klein, U.1
Lia, M.2
Crespo, M.3
-
54
-
-
84920024296
-
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
-
Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477-2487.
-
(2014)
N Engl J Med
, vol.371
, Issue.26
, pp. 2477-2487
-
-
Genovese, G.1
Kähler, A.K.2
Handsaker, R.E.3
-
55
-
-
84920053873
-
Age-related clonal hematopoiesis associated with adverse outcomes
-
Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488-2498.
-
(2014)
N Engl J Med
, vol.371
, Issue.26
, pp. 2488-2498
-
-
Jaiswal, S.1
Fontanillas, P.2
Flannick, J.3
-
56
-
-
80051589767
-
Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia
-
Kikushige Y, Ishikawa F, Miyamoto T, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 2011;20(2):246-259.
-
(2011)
Cancer Cell
, vol.20
, Issue.2
, pp. 246-259
-
-
Kikushige, Y.1
Ishikawa, F.2
Miyamoto, T.3
-
57
-
-
84945940347
-
Subclonal driver mutations predict shorter progression free survival in chronic lymphocytic leukemia following first-line chemo(immuno) therapy: Results from the CLL8 trial
-
abstract
-
Landau DA, Tausch E, Taylor-Weiner AN, et al. Subclonal driver mutations predict shorter progression free survival in chronic lymphocytic leukemia following first-line chemo(immuno) therapy: results from the CLL8 trial [abstract]. Blood. 2014;124(21). Abstract 1938.
-
(2014)
Blood
, vol.124
, Issue.21
-
-
Landau, D.A.1
Tausch, E.2
Taylor-Weiner, A.N.3
-
58
-
-
84863785266
-
Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia
-
Knight SJL, Yau C, Clifford R, et al. Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia. Leukemia. 2012;26(7):1564-1575.
-
(2012)
Leukemia
, vol.26
, Issue.7
, pp. 1564-1575
-
-
Knight, S.J.L.1
Yau, C.2
Clifford, R.3
-
59
-
-
84863774653
-
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse
-
Braggio E, Kay NE, VanWier S, et al. Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse. Leukemia. 2012;26(7):1698-1701.
-
(2012)
Leukemia
, vol.26
, Issue.7
, pp. 1698-1701
-
-
Braggio, E.1
Kay, N.E.2
VanWier, S.3
-
60
-
-
84869753284
-
Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns
-
Schuh A, Becq J, Humphray S, et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood. 2012;120(20):4191-4196.
-
(2012)
Blood
, vol.120
, Issue.20
, pp. 4191-4196
-
-
Schuh, A.1
Becq, J.2
Humphray, S.3
-
61
-
-
84961289235
-
Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia
-
Ojha J, Ayres J, Secreto C, et al. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia. Blood. 2015;125(3):492-498.
-
(2015)
Blood
, vol.125
, Issue.3
, pp. 492-498
-
-
Ojha, J.1
Ayres, J.2
Secreto, C.3
-
62
-
-
60549113518
-
B-cell clones as early markers for chronic lymphocytic leukemia
-
Landgren O, Albitar M, Ma W, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360(7):659-667.
-
(2009)
N Engl J Med
, vol.360
, Issue.7
, pp. 659-667
-
-
Landgren, O.1
Albitar, M.2
Ma, W.3
-
63
-
-
84926984290
-
Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression
-
Ojha J, Secreto C, Rabe K, et al. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression. Leukemia. 2014;28(12):2395-2398.
-
(2014)
Leukemia
, vol.28
, Issue.12
, pp. 2395-2398
-
-
Ojha, J.1
Secreto, C.2
Rabe, K.3
-
64
-
-
84925229458
-
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
-
Eirew P, Steif A, Khattra J, et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature. 2015;518(7539):422-426.
-
(2015)
Nature
, vol.518
, Issue.7539
, pp. 422-426
-
-
Eirew, P.1
Steif, A.2
Khattra, J.3
-
65
-
-
84902668801
-
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
-
Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396-1401.
-
(2014)
Science
, vol.344
, Issue.6190
, pp. 1396-1401
-
-
Patel, A.P.1
Tirosh, I.2
Trombetta, J.J.3
-
66
-
-
84900529199
-
Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq
-
Treutlein B, Brownfield DG, Wu AR, et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature. 2014;509(7500):371-375.
-
(2014)
Nature
, vol.509
, Issue.7500
, pp. 371-375
-
-
Treutlein, B.1
Brownfield, D.G.2
Wu, A.R.3
-
67
-
-
84891861044
-
Clonal evolution in hematological malignancies and therapeutic implications
-
Landau DA, Carter SL, Getz G, Wu CJ. Clonal evolution in hematological malignancies and therapeutic implications. Leukemia. 2014;28(1):34-43.
-
(2014)
Leukemia
, vol.28
, Issue.1
, pp. 34-43
-
-
Landau, D.A.1
Carter, S.L.2
Getz, G.3
Wu, C.J.4
-
68
-
-
84902163170
-
Clonal evolution in patients with chronic lymphocytic leukemia (CLL) developing resistance to BTK inhibition
-
abstract
-
Burger JA, Landau D, Hoellenriegel J, et al. Clonal evolution in patients with chronic lymphocytic leukemia (CLL) developing resistance to BTK inhibition [abstract]. Blood. 2013;122(21). Abstract 866.
-
(2013)
Blood
, vol.122
, Issue.21
-
-
Burger, J.A.1
Landau, D.2
Hoellenriegel, J.3
-
69
-
-
80053144962
-
A decade of exploring the cancer epigenome - Biological and translational implications
-
Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11(10):726-734.
-
(2011)
Nat Rev Cancer
, vol.11
, Issue.10
, pp. 726-734
-
-
Baylin, S.B.1
Jones, P.A.2
-
70
-
-
79959674418
-
Epigenetics of haematopoietic cell development
-
Cedar H, Bergman Y. Epigenetics of haematopoietic cell development. Nat Rev Immunol. 2011;11(7):478-488.
-
(2011)
Nat Rev Immunol
, vol.11
, Issue.7
, pp. 478-488
-
-
Cedar, H.1
Bergman, Y.2
-
71
-
-
0037076279
-
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
-
Bichi R, Shinton SA, Martin ES, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA. 2002;99(10):6955-6960.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, Issue.10
, pp. 6955-6960
-
-
Bichi, R.1
Shinton, S.A.2
Martin, E.S.3
-
72
-
-
69449100327
-
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia
-
Chen S-S, Raval A, Johnson AJ, et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2009;106(32):13433-13438.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, Issue.32
, pp. 13433-13438
-
-
Chen, S.-S.1
Raval, A.2
Johnson, A.J.3
-
73
-
-
0035100284
-
TCL1 is activated by chromosomal rearrangement or by hypomethylation
-
Yuille MR, Condie A, Stone EM, et al. TCL1 is activated by chromosomal rearrangement or by hypomethylation. Genes Chromosomes Cancer. 2001;30(4):336-341.
-
(2001)
Genes Chromosomes Cancer
, vol.30
, Issue.4
, pp. 336-341
-
-
Yuille, M.R.1
Condie, A.2
Stone, E.M.3
-
74
-
-
34249314024
-
Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia
-
Raval A, Tanner SM, Byrd JC, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 2007;129(5):879-890.
-
(2007)
Cell
, vol.129
, Issue.5
, pp. 879-890
-
-
Raval, A.1
Tanner, S.M.2
Byrd, J.C.3
-
75
-
-
84904011188
-
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
-
Claus R, Lucas DM, Ruppert AS, et al. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood. 2014;124(1):42-48.
-
(2014)
Blood
, vol.124
, Issue.1
, pp. 42-48
-
-
Claus, R.1
Lucas, D.M.2
Ruppert, A.S.3
-
76
-
-
70350452269
-
miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia
-
Pallasch CP, Patz M, Park YJ, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 2009;114(15):3255-3264.
-
(2009)
Blood
, vol.114
, Issue.15
, pp. 3255-3264
-
-
Pallasch, C.P.1
Patz, M.2
Park, Y.J.3
-
77
-
-
84864856010
-
Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia
-
Baer C, Claus R, Frenzel LP, et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res. 2012;72(15):3775-3785.
-
(2012)
Cancer Res
, vol.72
, Issue.15
, pp. 3775-3785
-
-
Baer, C.1
Claus, R.2
Frenzel, L.P.3
-
78
-
-
84876830254
-
Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB
-
Garding A, Bhattacharya N, Claus R, et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet. 2013;9(4):e1003373.
-
(2013)
PLoS Genet
, vol.9
, Issue.4
-
-
Garding, A.1
Bhattacharya, N.2
Claus, R.3
-
79
-
-
84655162785
-
Regions of focal DNA hypermethylation and longrange hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains
-
Berman BP, Weisenberger DJ, Aman JF, et al. Regions of focal DNA hypermethylation and longrange hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet. 2011;44(1):40-46.
-
(2011)
Nat Genet
, vol.44
, Issue.1
, pp. 40-46
-
-
Berman, B.P.1
Weisenberger, D.J.2
Aman, J.F.3
-
80
-
-
84882884517
-
Charting a dynamic DNA methylation landscape of the human genome
-
Ziller MJ, Gu H, Müller F, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013;500(7463):477-481.
-
(2013)
Nature
, vol.500
, Issue.7463
, pp. 477-481
-
-
Ziller, M.J.1
Gu, H.2
Müller, F.3
-
81
-
-
84875745673
-
Interplay between the cancer genome and epigenome
-
Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell. 2013;153(1):38-55.
-
(2013)
Cell
, vol.153
, Issue.1
, pp. 38-55
-
-
Shen, H.1
Laird, P.W.2
-
82
-
-
84858414016
-
Regulated noise in the epigenetic landscape of development and disease
-
Pujadas E, Feinberg AP. Regulated noise in the epigenetic landscape of development and disease. Cell. 2012;148(6):1123-1131.
-
(2012)
Cell
, vol.148
, Issue.6
, pp. 1123-1131
-
-
Pujadas, E.1
Feinberg, A.P.2
-
83
-
-
77957664665
-
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, openlabel, phase 3 trial
-
Hallek M, Fischer K, Fingerle-Rowson G, et al International Group of Investigators; German Chronic Lymphocytic Leukaemia Study Group. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, openlabel, phase 3 trial. Lancet. 2010;376(9747):1164-1174.
-
(2010)
Lancet
, vol.376
, Issue.9747
, pp. 1164-1174
-
-
Hallek, M.1
Fischer, K.2
Fingerle-Rowson, G.3
-
84
-
-
84899087266
-
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
-
Rossi D, Khiabanian H, Spina V, et al. Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. Blood. 2014;123(14):2139-2147.
-
(2014)
Blood
, vol.123
, Issue.14
, pp. 2139-2147
-
-
Rossi, D.1
Khiabanian, H.2
Spina, V.3
-
85
-
-
84860773361
-
Risk categories and refractory CLL in the era of chemoimmunotherapy
-
Zenz T, Gribben JG, Hallek M, Döhner H, Keating MJ, Stilgenbauer S. Risk categories and refractory CLL in the era of chemoimmunotherapy. Blood. 2012;119(18):4101-4107.
-
(2012)
Blood
, vol.119
, Issue.18
, pp. 4101-4107
-
-
Zenz, T.1
Gribben, J.G.2
Hallek, M.3
Döhner, H.4
Keating, M.J.5
Stilgenbauer, S.6
-
86
-
-
84924668392
-
Efficacy and safety of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic leukemia with 17p deletion: Results from the phase II RESONATE™-17 trial
-
abstract
-
O'Brien S, Jones JA, Coutre S, et al. Efficacy and safety of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic leukemia with 17p deletion: results from the phase II RESONATE™-17 trial [abstract]. Blood. 2014;124(21). Abstract 327.
-
(2014)
Blood
, vol.124
, Issue.21
-
-
O'Brien, S.1
Jones, J.A.2
Coutre, S.3
-
87
-
-
84924378555
-
Second interim analysis of a phase 3 study of idelalisib (ZYDELIG®) plus rituximab (R) for relapsed chronic lymphocytic leukemia (CLL): Efficacy analysis in patient subpopulations with Del(17p) and other adverse prognostic factors
-
abstract
-
Sharman JP, Coutre SE, Furman RR, et al. Second interim analysis of a phase 3 study of idelalisib (ZYDELIG®) plus rituximab (R) for relapsed chronic lymphocytic leukemia (CLL): efficacy analysis in patient subpopulations with Del(17p) and other adverse prognostic factors [abstract]. Blood. 2014;124(21). Abstract 330.
-
(2014)
Blood
, vol.124
, Issue.21
-
-
Sharman, J.P.1
Coutre, S.E.2
Furman, R.R.3
-
88
-
-
84907284539
-
Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL)
-
Komarova NL, Burger JA, Wodarz D. Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL). Proc Natl Acad Sci USA. 2014;111(38):13906-13911.
-
(2014)
Proc Natl Acad Sci USA
, vol.111
, Issue.38
, pp. 13906-13911
-
-
Komarova, N.L.1
Burger, J.A.2
Wodarz, D.3
-
89
-
-
84925797465
-
Haematological malignancies: At the forefront of immunotherapeutic innovation
-
Bachireddy P, Burkhardt UE, Rajasagi M, Wu CJ. Haematological malignancies: at the forefront of immunotherapeutic innovation. Nat Rev Cancer. 2015;15(4):201-215.
-
(2015)
Nat Rev Cancer
, vol.15
, Issue.4
, pp. 201-215
-
-
Bachireddy, P.1
Burkhardt, U.E.2
Rajasagi, M.3
Wu, C.J.4
-
90
-
-
66349121917
-
Adaptive therapy
-
Gatenby RA, Silva AS, Gillies RJ, Frieden BR. Adaptive therapy. Cancer Res. 2009;69(11):4894-4903.
-
(2009)
Cancer Res
, vol.69
, Issue.11
, pp. 4894-4903
-
-
Gatenby, R.A.1
Silva, A.S.2
Gillies, R.J.3
Frieden, B.R.4
-
91
-
-
77958020833
-
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: A retrospective study from the EBMT registry
-
Michallet M, Sobh M, Milligan D, et al Chronic Leukemia Working Party of the EBMT. The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry. Leukemia. 2010;24(10):1725-1731.
-
(2010)
Leukemia
, vol.24
, Issue.10
, pp. 1725-1731
-
-
Michallet, M.1
Sobh, M.2
Milligan, D.3
-
92
-
-
84883532609
-
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
-
Burkhardt UE, Hainz U, Stevenson K, et al. Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. J Clin Invest. 2013;123(9):3756-3765.
-
(2013)
J Clin Invest
, vol.123
, Issue.9
, pp. 3756-3765
-
-
Burkhardt, U.E.1
Hainz, U.2
Stevenson, K.3
-
93
-
-
80051720194
-
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
-
Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365(8):725-733.
-
(2011)
N Engl J Med
, vol.365
, Issue.8
, pp. 725-733
-
-
Porter, D.L.1
Levine, B.L.2
Kalos, M.3
Bagg, A.4
June, C.H.5
|